Legal Cannabis Industry is the Most Prolific Job Creator in America – Supporting More Than 428,000 Jobs
February 25, 2022
SEATTLE–(BUSINESS WIRE)–Leafly (LFLY), one of the leading online cannabis discovery marketplaces and resources for cannabis consumers, today released its sixth annual cannabis industry jobs report. This year’s report found there are now 428,059 full-time equivalent jobs supported by the legal cannabis industry in the U.S. Leafly’s research also shows that America’s 11... Read more
Xebra Announces Private Placement
February 25, 2022
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that it has entered into a firm agreement in connection with the sale of its former cannabis... Read more
Working with its partners in Colombia, CannabCo has compiled an economic assessment report related to their operations in Colombia. The report outlines CannabCo’s 5 major projects in relation to their economic impact on each region of operation. Three of the operations are in the Cundinamarca region approximately one hour outside Bogota,... Read more
Item 9 Labs’ Best-Selling Live Resin Pod System Set to Accelerate and Redefine Cannabis Experience
February 24, 2022
The Orion 710 Live Resin Pod and Battery System is a next-generation vape system that provides full-spectrum flower experiences on the go. It features strain-specific live resin extracted from fresh-frozen flower for incredible taste and enhanced effects, complemented by an innovative vaporizing device that offers a satisfying draw, magnetic interchangeable pods,... Read more
Chalice Brands Ltd. Pre-announces 61% Year Over Year Fourth Quarter Growth and Record Yearly Revenues
February 24, 2022
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
TripSitter.Clinic Announces Services Now Available to Almost Half the United States
February 24, 2022
Ryan Allway February 24th, 2022 News, Top News TORONTO, Feb. 24, 2022 /PRNewswire/ – Tripsitter Clinic Ltd. (CSE: KETA) (FSE: UY0) (“TripSitter.Clinic” or the “Company“), a virtual clinic and tele-health company, is pleased to announce that we now have providers in 23 states. These states include Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, North Dakota, Oklahoma, Tennessee, Vermont, Washington, West Virginia, Wisconsin, and Wyoming. Tripsitter.Clinic... Read more
Introducing SeaWeed Naturals From Ashlan & Philippe Cousteau
February 24, 2022
LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) — Created by globally renowned environmentalists Ashlan and Philippe Cousteau (grandson of Jacques Cousteau), SeaWeed Naturals’ premium beauty and wellness products harness the healing powers of the ocean, all while restoring it. Combining the benefits of restoratively farmed seaweed and algae with... Read more
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
February 24, 2022
PARK CITY, Utah–(BUSINESS WIRE)–Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021. Key Program & Corporate Updates In December announced that Pfizer Inc. and Arena entered into a definitive agreement under which Pfizer... Read more
AbbVie Inc. (ABBV) Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients
Uncategorized February 24, 2022
AbbVie Announces Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with…
The post AbbVie Inc. (ABBV) Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
